Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Indrayani Biotech Ltd Performance

Today's Low
51.00
arrowIcon
Today's High
54.50
52 Wk Low
46.80
arrowIcon
52 Wk High
99.70


Open

53.2

Traded Value (Cr)

15.90 L

Prev. Close

52.91

VWAP

52

Volume

30,829

Face Value

10

Indrayani Biotech Ltd Fundamentals

Market Cap
₹ 191 Cr
P/E Ratio (TTM)
26.46
P/B Ratio
3.52
Debt to Equity
1.53
ROE
14.99 %
EPS (TTM)
2.00
Dividend Yield
0.00%
Book Value
15.03

Click here to know more about Fundamentals

Indrayani Biotech Ltd Financials

Indrayani Biotech Ltd Financials

Indrayani Biotech Ltd Shareholding Pattern

Held By Apr 2024 Mar 2024 Dec 2023 Sep 2023
Retail 55.78 % 44.33 % 53.28 % 35.44 %
Promoters 33.57 % 42.13 % 33.63 % 44.84 %
Others 10.65 % 13.54 % 13.09 % 19.72 %
FII 0.00 % 0.00 % 0.00 % 0.00 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Retail

55.78%

Promoters

33.57%

Others

10.65%

FII

0.00%

Mutual Funds

0.00%

Retail

44.33%

Promoters

42.13%

Others

13.54%

FII

0.00%

Mutual Funds

0.00%

Retail

53.28%

Promoters

33.63%

Others

13.09%

FII

0.00%

Mutual Funds

0.00%

Retail

35.44%

Promoters

44.84%

Others

19.72%

FII

0.00%

Mutual Funds

0.00%

Resistance and Support

₹51.95

PIVOT

resistance-arrow
Resistance
First Resistance₹53.030
Second Resistance₹53.580
Third Resistance₹54.660
support-arrow
Support
First Resistance₹51.400
Second Resistance₹50.320
Third Resistance₹49.770
RSI30.410
MACD-3.304
ADX12.976
CCI-103.724

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day13,44630,829100.00
Week20,47320,473100.00
1 Month23,93123,931100.00
6 Months000.00

About Indrayani Biotech Ltd

Indrayani Biotech Limited was incorporated in 1992. The Company came out with a public issue in 1994 to part-finance its project to produce cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds. Presently, the Company is engaged in manufacture of electric motors, generators, transformers and electricity distribution and control apparatus Technical agreements have been signed with Floral Max, Malaysia; for rose cultivation; and with B L McKenzie and Associates, New Zealand, for tissue culture. The planting material for strawberries has been acquired from the US. The company has signed a test agreement with the Technology Transfer Offer of the University of California to obtain certified planting material from nurseries in California. IBL started exporting flowers to Holland and Dubai during 1994-95. Restricted water supply and changes in ecology resulted in a shortfall in achieving its goals. In 1995-96, the company incurred losses due to reasons beyond the control of the management like insufficient water supply, labour problem and sub-standard infrastructure. To overcome the above problems, the company is considering to shift its green houses to alternate locations. During the year 2010-11, the Scheme of Arrangement, seeking to reduce the equity share capital of the Company by 88%, conversion of unsecured loan into the equity shares, demerging the entire business into Indrayani Tissue Culture Pvt. Ltd., merging YoGoYo Division of Websource Technologies Ltd., was effective from August 21, 2010. Similarly, the Scheme of Arrangement for Amalgamation of Helios Solutions Limited and A-Diet Express Hospitality Services Limited as a going concern with the Company was made effective from April 1, 2018. IBL Investments Ltd was incorporated as wholly owned subsidiary company in 2022-23; Dindigul Farm Product Pvt Ltd became subsidiary in 2022-23.

Managing Director

Kasiraman Sayee Sundar

Founded

1992

NSE Symbol

Indrayani Biotech Ltd Management

NameDesignation
Kasiraman Sayee SundarED / MD / Promoter
Singarababu IndirakumarWhole-time Director
Muthu Krishnan RameshWhole-time Director
K S VaidyanathanIndependent Non Exe. Director
G SwaminathanWhole-time Director
Lakshmi PrabhaNon-Exec & Non-Independent Dir
N M RanganathanChairman & Independent Directo
B N Padmaja PriyadarshiniIndependent Non Exe. Director
V Santhana KrishnanCompany Sec. & Compli. Officer

Indrayani Biotech Ltd News

Indrayani Biotech consolidated net profit declines 56.10% in the December 2023 quarter
Sales decline 15.02% to Rs 39.09 crore
Indrayani Biotech announces board meeting date
On 10 February 2024
Indrayani Biotech to discuss results
On 10 January 2024
Indrayani Biotech consolidated net profit rises 5.32% in the September 2023 quarter
Sales decline 3.83% to Rs 40.44 crore
Indrayani Biotech to conduct board meeting
On 14 November 2023
Indrayani Biotech to conduct board meeting
On 1 November 2023
Indrayani Biotech to convene AGM
On 20 September 2023
Indrayani Biotech reports consolidated net loss of Rs 0.45 crore in the June 2023 quarter
Sales rise 65.08% to Rs 42.31 crore
Indrayani Biotech to convene board meeting
On 11 August 2023
Indrayani Biotech consolidated net profit declines 28.48% in the March 2023 quarter
Sales rise 185.51% to Rs 49.25 crore

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
INDHOTEL₹ 78,359 Cr
₹ 550.50
(-2.34 %)
68.30
EIHOTEL₹ 29,933 Cr
₹ 478.65
(-1.29 %)
55.85
CHALET₹ 18,097 Cr
₹ 829.80
(-4.32 %)
73.43
LEMONTREE₹ 11,527 Cr
₹ 145.50
(-4.43 %)
125.43
JUNIPER₹ 10,370 Cr
₹ 466.10
(-0.31 %)
0.00

Indrayani Biotech Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Indrayani Biotech Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Indrayani Biotech Ltd's share price is ₹51.56 as of May 9, 2024

Indrayani Biotech Ltd's P/E ratio is 26.46 times as of May 9, 2024.

Indrayani Biotech Ltd's most recent financial reports indicate a price-to-book ratio of 3.52, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Indrayani Biotech Ltd's market is 192 Cr as on May 9, 2024.

The current financial records of Indrayani Biotech Ltd show a 14.99% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Indrayani Biotech Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Indrayani Biotech Ltd's 52-week high and low as of May 9, 2024 are ₹54.5 and ₹51 respectively.

As of the Apr 2024 quarter, the promoter shareholding in Indrayani Biotech Ltd stands at 33.57%. During the same period, Institutional Investors have shown a slight values are equal in their holdings, values are equal from 0.00% to 0.00%.